Search research articles
Contact Us
Filters
Showing results (281-290 of 296) with videos related to
Page
of 30
Sort By:
European Urology Oncology
|
November 18, 2021
Integrative Clinical and Genomic Characterization of MTAP-deficient Metastatic Urothelial Cancer
Omar Alhalabi, Yueting Zhu, Ameer Hamza, et al.
Scientific Reports
|
September 1, 2018
OncomiR-10b hijacks the small molecule inhibitor linifanib in human cancers
Paloma Del C Monroig-Bosque, Maitri Y Shah, Xiao Fu, et al.
Cancers
|
December 10, 2021
Association of High-Intensity Exercise with Renal Medullary Carcinoma in Individuals with Sickle Cell Trait: Clinical Observations and Experimental Animal Studies
Daniel D Shapiro, Melinda Soeung, Luigi Perelli, et al.
Der Nervenarzt
|
May 28, 2021
[Telemedicine in stroke-pertinent to stroke care in Germany]
J Barlinn, S Winzer, H Worthmann, et al.
The New England Journal of Medicine
|
March 3, 2021
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Toni K Choueiri, Thomas Powles, Mauricio Burotto, et al.
Nature Medicine
|
October 13, 2020
Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma
Jianjun Gao, Neema Navai, Omar Alhalabi, et al.
The Lancet. Oncology
|
September 7, 2025
Metastasis-directed radiotherapy without systemic therapy for oligometastatic clear-cell renal-cell carcinoma: primary efficacy analysis of a single-arm, single-centre, phase 2 trial
Chad Tang, Alexander D Sherry, Aaron Seo, et al.
The Lancet. Gastroenterology & Hepatology
|
March 16, 2025
Software-based versus visual assessment of the minimal ablative margin in patients with liver tumours undergoing percutaneous thermal ablation (COVER-ALL): a randomised phase 2 trial
Bruno C Odisio, Jessica Albuquerque, Yuan-Mao Lin, et al.
Nature Communications
|
July 4, 2024
Author Correction: Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy
Sang T Kim, Yanshuo Chu, Mercy Misoi, et al.
Nature Communications
|
April 13, 2022
Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy
Sang T Kim, Yanshuo Chu, Mercy Misoi, et al.
Page
of 30
Search research articles
Search
Showing results (281-290 of 296) with videos related to
Sort By:
Page
of 30
European Urology Oncology
|
November 18, 2021
Integrative Clinical and Genomic Characterization of MTAP-deficient Metastatic Urothelial Cancer
Omar Alhalabi, Yueting Zhu, Ameer Hamza, et al.
Scientific Reports
|
September 1, 2018
OncomiR-10b hijacks the small molecule inhibitor linifanib in human cancers
Paloma Del C Monroig-Bosque, Maitri Y Shah, Xiao Fu, et al.
Cancers
|
December 10, 2021
Association of High-Intensity Exercise with Renal Medullary Carcinoma in Individuals with Sickle Cell Trait: Clinical Observations and Experimental Animal Studies
Daniel D Shapiro, Melinda Soeung, Luigi Perelli, et al.
Der Nervenarzt
|
May 28, 2021
[Telemedicine in stroke-pertinent to stroke care in Germany]
J Barlinn, S Winzer, H Worthmann, et al.
The New England Journal of Medicine
|
March 3, 2021
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Toni K Choueiri, Thomas Powles, Mauricio Burotto, et al.
Nature Medicine
|
October 13, 2020
Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma
Jianjun Gao, Neema Navai, Omar Alhalabi, et al.
The Lancet. Oncology
|
September 7, 2025
Metastasis-directed radiotherapy without systemic therapy for oligometastatic clear-cell renal-cell carcinoma: primary efficacy analysis of a single-arm, single-centre, phase 2 trial
Chad Tang, Alexander D Sherry, Aaron Seo, et al.
The Lancet. Gastroenterology & Hepatology
|
March 16, 2025
Software-based versus visual assessment of the minimal ablative margin in patients with liver tumours undergoing percutaneous thermal ablation (COVER-ALL): a randomised phase 2 trial
Bruno C Odisio, Jessica Albuquerque, Yuan-Mao Lin, et al.
Nature Communications
|
July 4, 2024
Author Correction: Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy
Sang T Kim, Yanshuo Chu, Mercy Misoi, et al.
Nature Communications
|
April 13, 2022
Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy
Sang T Kim, Yanshuo Chu, Mercy Misoi, et al.
Page
of 30